Fatima, Farhat http://orcid.org/0000-0002-5549-8649
Hjelmesæth, Jøran
Hertel, Jens Kristoffer
Svanevik, Marius
Sandbu, Rune
Småstuen, Milada Cvancarova
Hofsø, Dag
Funding for this research was provided by:
helse sør-øst rhf
Article History
Received: 23 June 2021
Revised: 14 December 2021
Accepted: 17 December 2021
First Online: 4 January 2022
Declarations
:
: All participants provided a written informed consent. The study protocol was approved by the Regional Committees for Medical and Health Research Ethics (ref: 2012/1427/REK sør-øst) and is in accordance with the Helsinki-II declaration.
: F.F. declares an educational grant (PhD) from South-Eastern Norway, Regional Health Authority during the conduct of the study. J.H. declares honoraria from Novo Nordisk, Boehringer Ingelheim and Navamedic, outside the submitted work. D.H. declares honoraria from Novo Nordisk, Lilly and Sanofi, outside the submitted work. Other authors have no conflict of interest.
: The funder of the study had no role in study design, data collection, data analyses, data interpretation or writing of the report. All authors had independent access to the data and took responsibility for data completeness and accuracy, and for the fidelity of the trial to the protocol. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.